Additional detail required for corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories Limited has informed the BSE that three Non-Executive Independent Directors — Mathura Prasad Sharma, Toby Antony, and Nandkumar Pareek — resigned from the board with effect from April 16, 2025. The company stated the reason for their resignation is the open offer made by the acquirer M/s Atibha Agriseeds Private Limited. The directors have confirmed they do not hold directorship in any other listed company. The company clarified there is no other reason for their exit. The communication was signed by Director Ashok Somani.
The exit of all three independent directors at once weakens board independence and signals a major change in ownership/control via the open offer. Shareholders should watch for new appointments and any impact on governance, though the resignations appear linked to the takeover rather than internal issues.